Friday, 30 September 2011

NewsBite: Combination Antifungal Drug Trial Disappoints

Reuters article: Pharmaceutical company Pfizer's trial featured two of their antifungal drugs given together to treat invasive aspergillosis. Vfend (voriconazole) and Eraxis (anidulafungin) given together appeared to show some improvement over using Vfend alone but the data was not statistically significant in the final analysis.
more...

No comments:

Amazon Contextual Product Ads

Contact us at admin@aspergillus.org.uk